Persistent Atrial Fibrillation Clinical Trial
Official title:
Prospective, Randomized Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone Versus Hybrid Ablation With Pulmonary Vein Isolation Plus Catheter Ablation for CFAE and Linear Lesions
The overall objective of the study is to compare and assess the clinical outcomes of the standard of care hybrid ablation using epicardial ablation in conjunction with endocardial PVI alone versus epicardial ablation in conjunction with endocardial ablation using PVI with additional RF ablation in a randomized, prospective population of patients with persistent AF of at least 6 months duration. All devices that are used are being utilized under the approved labeling of the devices.
Atrial fibrillation (AF) is one of the leading causes of stroke and heart failure. It is also
a major cause of hospitalizations and mortality (Stewart, Wattigney, and Wolf). Patients with
atrial fibrillation (AF) who are intolerant to Class I and III antiarrhythmic drugs often
require endocardial ablation, which can include pulmonary vein isolation (PVI) using
radiofrequency (RF) catheter ablation or cryoballoon ablation (Medtronic, MN) and reported
success rates vary (Calkins et al). In patients with persistent and long standing persistent
AF success rates may not be as high (Akoum et al) and there is little data analyzing outcomes
for patients in this population (Calkins et al). Using an epicardial-endocardial, or hybrid,
approach Gehi et al describes a 66% 12 month arrythmia-free survival rate following the
procedure, with 37% patients still on antiarrythmic drug therapy at 12 months. Furthermore, a
paper by Anderson et al reports that the hybrid ablation results in lower costs and higher
quality adjusted life years for patients with non-paroxysmal AF as reported by the studie's
results of fewer repeat ablations and maintenance of sinus rhythm at 5 years. Conflicting
reports exist on how much endocardial catheter ablation is needed for patients in persistent
and long standing persistent AF. Verma et al reports results for patients in persistent AF
having endocardial PVI compared to P VI plus additional linear lesions. Eighteen month
success rates for these patients were 59% and 46% respectively.
Success of surgical hybrid ablation using epicardial ablation cocontaminent with endocardial
PVI alone versus the hybrid approach using epicardial ablation with endocardial ablation
consisting of PVI ablation and RF ablation has not been studied using a randomized,
prospective approach.
If it is found that the PVI alone is as effective as PVI plus additional catheter ablation
for patients receiving a hybrid ablation, it may reduce the need for extensive catheter
ablation, thereby reducing the radiation exposure, procedure time, and radiofrequency
ablation time.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05970120 -
A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter
|
N/A | |
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT03650556 -
Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation
|
N/A | |
Recruiting |
NCT04085731 -
Driver-guided Ablation of Persistent Atrial Fibrillatiom
|
||
Completed |
NCT01694563 -
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
|
N/A | |
Terminated |
NCT01683045 -
Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats
|
N/A | |
Active, not recruiting |
NCT03643224 -
DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
|
N/A | |
Withdrawn |
NCT05093868 -
Electrographic Flow Mapping Validation in Patients With Persistent Atrial Fibrillation (EVAL AF)
|
N/A | |
Completed |
NCT05152966 -
Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)
|
N/A | |
Completed |
NCT05043883 -
Automated Assessment of PVI Using a Novel EP Recording System
|
N/A | |
Completed |
NCT04022954 -
HD Mapping of Atrial Fibrillation in Asia Pacific
|
||
Active, not recruiting |
NCT06124690 -
Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas
|
N/A | |
Completed |
NCT06260670 -
FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT05454111 -
CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation
|
N/A | |
Active, not recruiting |
NCT05077670 -
Hybrid Characterization of Driver Sites During Atrial Fibrillation and Sinus Rhythm
|
||
Withdrawn |
NCT03835338 -
WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm
|
N/A | |
Completed |
NCT02275104 -
Multimodal Image Processing Software to Guide Cardiac Ablation Therapy
|
N/A | |
Not yet recruiting |
NCT05565183 -
Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation.
|
N/A | |
Completed |
NCT02274857 -
Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures
|
N/A | |
Completed |
NCT01014741 -
Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation
|
N/A |